Toric Intraocular Lens

Dr. Connie Wu is a board-certified ophthalmologist with fellowship training in glaucoma and expertise in cataract and complex glaucoma surgery. She completed the combined BA/MD program at Brown University, graduating with highest distinction and election to Alpha Omega Alpha. Her ophthalmology residency and glaucoma fellowship were completed at the renowned Wills Eye Hospital, where she received the William Tasman Outstanding Fellow Award. Dr. Wu specializes in a full range of glaucoma treatments, including MIGS procedures, trabeculectomy, tube shunts, laser therapies, and cataract surgery with advanced technology lenses. She is passionate about forming long-term partnerships with her patients through individualized, evidence-based care. With prior experience as an assistant professor at the world renowned Bascom Palmer Eye Institute and a current adjunct clinical instructor at Stanford, Dr. Wu has authored numerous publications, contributed to the Wills Eye Manual, and served as an invited instructor at national ophthalmology conferences. Her research interests include surgical innovation, glaucoma laser therapies, and improving access to care. She is an active member of major ophthalmic societies and has strong roots in the Bay Area, where she enjoys serving her community.

Dr. Dane Slentz, MD is a board-certified oculofacial plastic and reconstructive surgeon specializing in the eyelids, orbit, and lacrimal (tear duct) system. He treats a full spectrum of oculoplastic conditions, including droopy eyelids and brows, eyelid malpositions (entropion/ectropion), periocular skin cancer with post-Mohs reconstruction, tearing and tear-duct disorders, thyroid eye disease, anophthalmic socket reconstruction, and orbital/periorbital trauma. He also offers neurotoxin (botulinum toxin) therapy for blepharospasm and facial spasm. Dr. Slentz completed an American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS)-approved, two-year oculoplastics fellowship at the University of Michigan following ophthalmology residency at The George Washington University, where he served as chief resident. His academic work includes peer-reviewed publications and textbook chapters, with particular interest in the use of umbilical amniotic membrane for eye-socket reconstruction. He is known for meticulous surgical technique and a warm, patient-centered approach that prioritizes safety, function, and natural-looking results.

Dr. Emily Eton is a board-certified ophthalmologist and vitreoretinal surgeon who cares for the full spectrum of medical and surgical retina conditions in both adults and children. She specializes in complex retinal detachment repair, macular surgery, scleral-fixated intraocular lenses, and advanced treatments for diabetic retinopathy, macular degeneration, and retinal vascular disease. She has particular expertise in pediatric retina, including retinopathy of prematurity (ROP), familial exudative vitreoretinopathy (FEVR), Coats’ disease, persistent fetal vasculature (PFV), and pediatric ocular trauma. Her research focuses on improving outcomes in pediatric retinal disease and strengthening ROP care delivery through standardized best practices and thoughtful training. Patients describe Dr. Eton as thorough, compassionate, and exceptionally clear in her explanations. She’s committed to individualized, evidence-based guidance so each patient and family understands their diagnosis and options—and can move forward with confidence.

Dr. Emily Schehlein, MD is a board-certified ophthalmologist with fellowship training in glaucoma and a high-volume surgeon specializing in cataract and glaucoma procedures. She brings extensive expertise in both routine and complex cases, offering cutting-edge, evidence-based care tailored to each patient’s needs. Dr. Schehlein is known for combining clinical precision with a warm, patient-centered approach. She currently works with multiple national organizations focused on advancing surgical innovation and sustainability in ophthalmology, including the American Academy of Ophthalmology and the American Society of Cataract and Refractive Surgery. Her research has been widely published in peer-reviewed journals, and she is an invited speaker at national and international conferences. Dr. Schehlein is deeply committed to delivering thoughtful, individualized second opinions to empower patients navigating complex eye conditions and treatment decisions.

Dr. Grayson Armstrong is a Harvard-trained ophthalmologist and public health leader focused on expanding access to eye care through innovation and policy. He earned his MD and MPH from Harvard, advising global organizations on refugee health and health systems. He completed residency at Harvard Ophthalmology, where he served as Chief Resident and led the Ocular Trauma Service at Mass Eye and Ear. A leader in organized medicine, he sits on the Board of Trustees of the American Medical Association. Dr. Armstrong is the founder of Ocular Technologies and a nationally recognized expert in telemedicine, AI, and digital health. He has published extensively and speaks nationally on emerging models of eye care.

Dr. Jose R. Davila is a vitreoretinal surgeon who manages both medical and surgical diseases of the retina, including retinal detachment, macular holes, epiretinal membranes, macular degeneration, diabetic retinopathy, and retinal vascular occlusions. His research interests span global ophthalmology, tele-retinal imaging, and surgical education.

Dr. Karen Chen is a glaucoma specialist with advanced training in minimally invasive glaucoma surgery, laser therapies, and cataract procedures. She earned her MD from Stanford and completed a master’s in epidemiology at the University of Cambridge as a Gates Cambridge Scholar. Her postgraduate training includes residency at Washington University in St. Louis and fellowship at Massachusetts Eye and Ear. With a strong foundation in public health, Dr. Chen integrates holistic, patient-centered care with a focus on innovation. Her research spans teleophthalmology, artificial intelligence, and care delivery models that improve access and efficiency. She also partners with global colleagues to advance surgical education and AI-assisted screenings in low-resource settings. Dr. Chen is an active member of leading ophthalmology societies and is committed to improving outcomes through both local and international collaboration.

Dr. Levi Kanu is a fellowship-trained cornea specialist with expertise in corneal transplantation, cataract surgery, refractive procedures, and the treatment of complex ocular surface diseases. He combines surgical excellence with a commitment to advancing ocular drug delivery through translational research. Dr. Kanu earned his undergraduate degree in chemical and biomolecular engineering from Johns Hopkins University and completed his medical degree at the University of Pennsylvania. He went on to train in ophthalmology at the Illinois Eye and Ear Infirmary, followed by a prestigious cornea fellowship. As a clinician-scientist and NIH/NEI-funded K12 Vision Scholar, Dr. Kanu’s research focuses on innovative treatments for corneal disease, including drug delivery technologies targeting conditions like neurotrophic keratopathy. His goal is to bridge laboratory discoveries with real-world impact, bringing meaningful therapies to patients with vision-threatening disorders. Dr. Kanu is passionate about delivering compassionate, evidence-based care while advancing the science of ophthalmology through thoughtful innovation.

Dr. Nicholas Carducci is a board-certified ophthalmologist specializing in cataract surgery and the medical management of retinal diseases, including macular degeneration, diabetic retinopathy, retinal vein occlusions, and retinal tears. He is highly skilled in laser and injection-based treatments, including YAG laser capsulotomy, retinal laser photocoagulation, and intravitreal injections with agents such as Avastin, Eylea, and Vabysmo. Dr. Carducci earned his undergraduate degree with honors in Cellular and Molecular Biology from the University of Michigan and completed medical school at the Perelman School of Medicine at the University of Pennsylvania. He returned to Michigan for residency and fellowship at the Kellogg Eye Center, where he received the Paul R. Lichter Resident Mentor Award. His clinical interests span medical retina, anterior segment surgery, and ophthalmic education. He has published in peer-reviewed journals and presented at national conferences. Dr. Carducci is a member of the American Academy of Ophthalmology and the American Society of Cataract and Refractive Surgery. Outside of work, he enjoys travel, fitness, and volunteering.